Found "AI": 1,118 results
How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings? (2016)
Yot Teerawattananon, Alia Luz* , Songyot Pilasant, Suteenoot Tangsathitkulchai, Sarocha Chootipongchaivat, Nattha Tritasavit, Inthira Yamabhai and Sripen Tantivess
Abstract
Background: It is very challenging for resource-limited settings to introduce universal health coverage (UHC), particular
One Step Back, Two Steps Forward: An Economic Evaluation of the PEN Program in Indonesia (2016)
Waranya Rattanavipapong1, Alia Cynthia Gonzales Luz1,*, Suthasinee Kumluang1,Nunik Kusumawardani2 and Yot Teerawattananon1
Co-investigators: Dewi Indriani3, Priska Apsari Primastuti3, Lily Banonah Rivai4,
Sri Idaiani2, Ully Adhie2, Thunyarat Anothaisintawee1, Sarocha Chootipongchaivat1,
Kanlaya T
Nationwide survey of nutritional management in an Asian upper-middle income developing country government hospitals: Combination of quantitative survey and focus group discussion (2016)
K. Chittawatanarat a, *, K. Tosanguan b, U. Chaikledkaew b, c, S. Tejavanija d, Y. Teerawattananon b
a Division of Trauma and Critical Care, Department of Surgery, Faculty of Medicine, Maharaj Nakorn Chiang Mai Hospital, Intawarorod Road, Sripume, Chiang Mai University, Chiang Mai 50200, Thailand
A Systematic Review of Economic Evaluation Methodologies Between Resource-Limited and Resource-Rich Countries: A Case of Rotavirus Vaccines (2016)
Kittiphong Thiboonboon1 , Benjarin Santatiwongchai1 ,Varit Chantarastapornchit1 , Waranya Rattanavipapong1 , Yot Teerawattananon1
Abstract
Background
For more than three decades, the number and influence of economic evaluations of healthcare interventions have been increasing and gaining atte
Vaccination program in a resource-limited setting: A case study in the Philippines
Objective: Implementing national-level vaccination programs involves long-term investment, which can be a significant financial burden, particularly in resource-limited settings. Although many studies have assessed the economic impacts of providing vaccinations, evidence on the positive and negative
An ex-ante economic evaluation of the Maternal and Child Health Voucher Scheme as a decision-making tool in Myanmar (2016)
Pritaporn Kingkaew1,*, PitsaphunWerayingyong1, San San Aye2,
Nilar Tin3, Alaka Singh4, Phone Myint2 and Yot Teerawattananon1
1Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand,
2Department of Health Planning and
3Department of He
Health Technology Assessment: Global Advocacy and Local RealitiesComment on “Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness” (2016)
Kalipso Chakidou1*, Ryan Li1, Anthony J. Culyer2, Amanda Glassman3, Karen J. Hofman4, Yot Teerawattananon5
1Institute of Global Health Innovation, Imperial College London, London, UK
2Department of Economics & Related Studies and Centre for Health Economics, University of York, York, UK
3Ce
Essential medicines for universal health coverage (2016)
Veronika J Wirtz*, Hans V Hogerzeil*, Andrew L Gray*, Maryam Bigdeli, Cornelis P de Joncheere, Margaret A Ewen, Martha Gyansa-Lutterodt,
Sun Jing, Vera L Luiza, Regina M Mbindyo, Helene Möller, Corrina Moucheraud, Bernard Pécoul, Lembit Rägo, Arash Rashidian,
Dennis Ross-Degnan, Peter N Stephens,
Maternal and child health voucher scheme in Myanmar: a review of early stage implementationv (2016)
Songyot Pilasant1, Wantanee Kulpeng1, Pitsaphun Werayingyong1*, Nattha Tritasavit1, Inthira Yamabhai1,
Yot Teerawattananon1, Sangay Wangmo2 and Sripen Tantivess1
Abstract
Background: The Maternal and Child Health Voucher Scheme (MCHVS) was introduced in Myanmar to address the high rate of mat
The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh (2016)
Background
Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low- and middle-income countries (LMICs) that include li
10 / Page